GLP-1 & Peptides, The Balanced Truth with Dr Josh Helman

There’s a conversation happening around GLP-1 drugs like Ozempic, Wegovy, and tirzepatide that feels strangely one-sided.

These medications are being marketed as breakthrough solutions for weight loss, and I understand why people are interested. So many people are exhausted by dieting and desperate for something that finally works. But on this episode of The Gaslit Truth Podcast, I wanted to slow the conversation down and ask harder questions.

I sat down again with Dr. Josh Hellman, a Harvard-trained physician and lifestyle medicine expert, for one of the most honest conversations I’ve heard yet about peptides and GLP-1 agonists. Not fear-mongering. Not pharmaceutical hype. Just a real discussion about what patients deserve to know before starting these medications.

One thing we talked about is how the body is not a simple math equation. Weight loss is about far more than eating less. Hormones, metabolism, muscle preservation, inflammation, and brain chemistry all matter — and when we artificially push one pathway hard enough, there can be trade-offs.

We discussed what peptides actually are, why dose and delivery matter, and how GLP-1 drugs can push signaling far beyond normal physiology. We also talked about the side effects that often get minimized: nausea and vomiting from slowed gastric emptying, gallbladder disease and pancreatitis risks, and the reality that “weight loss” can also mean significant muscle loss.

And then there’s the conversation that really stuck with me: reward pathways in the brain. Some people report reduced pleasure, lower drive, emotional flatness, and mood changes while taking these medications. Shouldn’t those conversations happen more openly?

This episode isn’t about fear or blind fandom. It’s about honesty and nuance. Dr. Hellman also shared where he sees cautious promise for brain health and Alzheimer’s prevention research, along with why he believes nutrition, resistance training, and lifestyle medicine still matter the moment the weekly shot stops.

Because that’s the bigger question no one seems to ask enough:

What happens after?

If you’re considering a GLP-1 medication, I hope this episode helps you ask better questions and think more critically before making a decision.

Listen to the full episode of The Gaslit Truth Podcast on YouTube! Share it with someone considering GLP-1 drugs, and leave a review if you want more conversations that challenge medical marketing and explore the topics many people are afraid to discuss.